|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
US5550214A
(en)
*
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
CA2366152A1
(en)
|
1999-03-19 |
2000-09-28 |
Smithkline Beecham Biologicals S.A. |
Streptococcus pneumoniae vaccine
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
EP1189624A4
(en)
*
|
1999-06-29 |
2005-02-23 |
Epimmune Inc |
Hla binding peptides and their uses
|
|
EP1568373A3
(en)
*
|
1999-12-10 |
2005-12-21 |
Epimmune Inc. |
Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions
|
|
WO2001058479A1
(en)
|
2000-02-08 |
2001-08-16 |
The Penn State Research Foundation |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
|
JP2003524016A
(ja)
*
|
2000-02-23 |
2003-08-12 |
エピミューン， インコーポレイテッド |
Ｈｌａ結合ペプチドおよびそれらの用途
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
CA2480008C
(en)
|
2002-03-22 |
2015-10-06 |
The Penn State Research Foundation |
Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
|
|
JP2006512300A
(ja)
|
2002-10-03 |
2006-04-13 |
エピミューン インコーポレイテッド |
Ｈｌａ結合ペプチド及びその使用
|
|
CN1954217B
(zh)
*
|
2004-02-06 |
2013-05-08 |
国立健康与医学研究所 |
衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途
|
|
WO2006034334A2
(en)
|
2004-09-21 |
2006-03-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
CA2672215A1
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
JP2010190572A
(ja)
*
|
2007-06-01 |
2010-09-02 |
Sapporo Medical Univ |
ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬
|
|
PT2170959E
(pt)
|
2007-06-18 |
2014-01-07 |
Merck Sharp & Dohme |
Anticorpos para o receptor humano de morte programada pd-1
|
|
KR101543624B1
(ko)
|
2007-08-20 |
2015-08-11 |
온코세라피 사이언스 가부시키가이샤 |
Ｆｏｘｍ１ 펩티드 및 이를 포함하는 약학적 조성물
|
|
US20110182926A1
(en)
*
|
2008-08-12 |
2011-07-28 |
Nicola La Monica |
Minigene
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
US20110033389A1
(en)
*
|
2009-04-29 |
2011-02-10 |
Zhifeng Chen |
Modified antibodies for passive immunotherapy
|
|
EP3279215B1
(en)
|
2009-11-24 |
2020-02-12 |
MedImmune Limited |
Targeted binding agents against b7-h1
|
|
US9314516B2
(en)
|
2010-05-04 |
2016-04-19 |
Cassian Yee |
Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses
|
|
WO2012027379A2
(en)
|
2010-08-24 |
2012-03-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
CA2902415C
(en)
|
2012-03-19 |
2024-02-06 |
Stemline Therapeutics, Inc. |
Methods for treating and monitoring the status of cancer
|
|
WO2013148147A1
(en)
|
2012-03-26 |
2013-10-03 |
The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services |
Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
WO2013173411A1
(en)
|
2012-05-16 |
2013-11-21 |
Stemline Therapeutics, Inc |
Cancer stem cell targeted cancer vaccines
|
|
US20140141044A1
(en)
*
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
EP2929045B1
(en)
|
2012-12-05 |
2020-12-02 |
SOLA Biosciences LLC |
Protein expression enhancing polypeptides
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
KR20160016725A
(ko)
*
|
2014-08-05 |
2016-02-15 |
주식회사 유영제약 |
암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포
|
|
JP7013240B2
(ja)
|
2015-02-16 |
2022-01-31 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｈｅｒ２／Ｎｅｕ （ＥＲＢＢ２）受容体タンパク質に由来する３６９～３７７位エピトープに特異的な完全ヒトＴ細胞受容体
|
|
WO2016146143A1
(en)
|
2015-03-16 |
2016-09-22 |
Amal Therapeutics Sa |
Cell penetrating peptides and complexes comprising the same
|
|
SG11201706418QA
(en)
*
|
2015-03-31 |
2017-10-30 |
Agency Science Tech & Res |
Method for antigen loading of dendritic cells and vaccine
|
|
US12018331B2
(en)
|
2016-05-23 |
2024-06-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
IL296165B2
(en)
|
2016-10-07 |
2023-10-01 |
Enterome S A |
Immunogenic compounds for cancer treatment
|
|
CN117801069A
(zh)
|
2016-10-07 |
2024-04-02 |
恩特罗姆公司 |
用于癌症疗法的免疫原性化合物
|
|
US11712465B2
(en)
|
2016-10-07 |
2023-08-01 |
Enterome S.A. |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
AU2018348432B2
(en)
|
2017-10-09 |
2025-08-28 |
Enterome S.A. |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
ES2935702T3
(es)
|
2018-04-11 |
2023-03-09 |
Enterome S A |
Péptidos antigénicos para la prevención y el tratamiento del cáncer
|
|
US20210106652A1
(en)
|
2018-04-11 |
2021-04-15 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation
|
|
MX2022004598A
(es)
|
2019-10-16 |
2022-09-23 |
Enterome S A |
Compuestos inmunogenicos para el tratamiento del cancer suprarrenal.
|
|
PL4021487T3
(pl)
|
2019-11-15 |
2024-04-15 |
Enterome S.A. |
Peptydy antygenowe do zapobiegania i leczenia nowotworów złośliwych wywodzących się z limfocytów b
|